Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ularitide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ularitide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(ularitide)
Trials
(ularitide)
Recent Studies (post-2010) (ularitide)
9,1561875522104122

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Featherstone, RL; Uhlig, S; Wendel, A; Wilhelms, OH1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ularitide

ArticleYear
Effect of urodilatin on platelet-activating factor-induced bronchoconstriction, vasoconstriction and edema formation in isolated rat lung.
    Naunyn-Schmiedeberg's archives of pharmacology, 1996, Volume: 354, Issue:5

    Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Bronchoconstriction; Bronchodilator Agents; Capillary Permeability; Edema; Female; Lung; Organ Size; Peptide Fragments; Perfusion; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxanes; Vascular Resistance; Vasoconstriction

1996